Drug and Narcotic Control -- statistics & numerical data : Lies, damned lies, and drug war statistics : a critical analysis of claims made by the Office of National Drug Control Policy / Matthew B. Robinson and Renee G. Scherlen
2014
1
Drug and Narcotics Control : Pot politics : marijuana and the costs of prohibition / edited by Mitch Earleywine
Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
Here are entered works on patients' practical or economic access to therapeutic drugs. Works on the physiological availability of administered drugs within the body are entered under Drugs--Bioavailability
Here are entered works on the physiological availability of administered drugs within the body. Works on patients' practical or economic access to therapeutic drugs are entered under Drug accessibility
Here are entered works on testing the effectiveness or safety of drugs. Works on testing to identify the personal use or misuse of drugs are entered under Drug testing. Technical works on chemical analysis to determine the composition or presence of drugs are entered under Drugs--Analysis --subdivision Testing under individual drugs and groups of drugs; and subdivision Therapeutic use--Testing under individual chemicals and groups of chemicals, e.g. Copper--Therapeutic use--Testing; Insulin--Therapeutic use--Testing
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers
Drug Carriers -- methods : Polymeric delivery of therapeutics / Sarah E. Morgan, editor, School of Polymers and High Performance Materials University of Southern Mississippi, Robert Y. Lochhead, editor, School of Polymers and High Performance Materials, University of Southern Mississippi ; sponsored by the ACS Division of Polymer Chemistry